Literature DB >> 8723086

Clinical and ultrastructural findings in three patients with geleophysic dysplasia.

B F Pontz1, H Stöss, F Henschke, P Freisinger, A Karbowski, J Spranger.   

Abstract

Geleophysics dysplasia, a rare disorder with autosomal-recessive inheritance, is characterized by short stature with a "happy-looking" facial appearance. Nonskeletal findings, particularly in an advanced stage, include hepatosplenomegaly and valvular cardiopathy. Based on the clinical picture and the detection of lysosome-like inclusions in hepatocytes, the underlying cause of the condition is considered to be a storage defect in the metabolism of glycoproteins. The clinical course, with progressive worsening of the condition favors this hypothesis. We report on 3 further cases, in which light and electron microscopic studies of iliac crest biopsies and cultured skin fibroblasts provided additional evidence that geleophysic dysplasia represents a lysosomal storage disease. The additional discovery of storage vacuoles in chondrocytes and skin fibroblasts strongly suggests that the condition is a generalized storage defect. To date, it has not yet been possible to identify the presumed biochemical defect in the metabolic pathways of glycoproteins.

Entities:  

Mesh:

Year:  1996        PMID: 8723086     DOI: 10.1002/(SICI)1096-8628(19960503)63:1<50::AID-AJMG11>3.0.CO;2-T

Source DB:  PubMed          Journal:  Am J Med Genet        ISSN: 0148-7299


  8 in total

1.  ADAMTSL2 mutations in geleophysic dysplasia demonstrate a role for ADAMTS-like proteins in TGF-beta bioavailability regulation.

Authors:  Carine Le Goff; Fanny Morice-Picard; Nathalie Dagoneau; Lauren W Wang; Claire Perrot; Yanick J Crow; Florence Bauer; Elisabeth Flori; Catherine Prost-Squarcioni; Deborah Krakow; Gaoxiang Ge; Daniel S Greenspan; Damien Bonnet; Martine Le Merrer; Arnold Munnich; Suneel S Apte; Valérie Cormier-Daire
Journal:  Nat Genet       Date:  2008-09       Impact factor: 38.330

2.  Two Patients with Severe Short Stature due to a FBN1 Mutation (p.Ala1728Val) with a Mild Form of Acromicric Dysplasia.

Authors:  Christiaan de Bruin; Courtney Finlayson; Mariana F A Funari; Gabriela A Vasques; Bruna Lucheze Freire; Antonio M Lerario; Melissa Andrew; Vivian Hwa; Andrew Dauber; Alexander A L Jorge
Journal:  Horm Res Paediatr       Date:  2016-06-02       Impact factor: 2.852

3.  Limb- and tendon-specific Adamtsl2 deletion identifies a role for ADAMTSL2 in tendon growth in a mouse model for geleophysic dysplasia.

Authors:  Dirk Hubmacher; Nandaraj Taye; Zerina Balic; Stetson Thacker; Sheila M Adams; David E Birk; Ronen Schweitzer; Suneel S Apte
Journal:  Matrix Biol       Date:  2019-02-07       Impact factor: 11.583

4.  Acromicric dysplasia: long term outcome and evidence of autosomal dominant inheritance.

Authors:  L Faivre; M Le Merrer; C Baumann; M Polak; P Chatelain; V Sulmont; J Cousin; M Bost; M P Cordier; E Zackai; K Russell; G Finidori; J C Pouliquen; A Munnich; P Maroteaux; V Cormier-Daire
Journal:  J Med Genet       Date:  2001-11       Impact factor: 6.318

5.  Clinical Phenotype of Musladin-Lueke Syndrome in 2 Beagles.

Authors:  R A Packer; M A Logan; L T Guo; S S Apte; H Bader; D P O'Brien; G Johnson; G D Shelton
Journal:  J Vet Intern Med       Date:  2017-02-03       Impact factor: 3.333

6.  Geleophysic dysplasia associated with bilateral angle closure glaucoma.

Authors:  Murat Sinan Saricaoglu; Dilek Güven; Ahmet Karakurt; Hikmet Hasiripi
Journal:  Indian J Ophthalmol       Date:  2013-03       Impact factor: 1.848

7.  Adamtsl2 deletion results in bronchial fibrillin microfibril accumulation and bronchial epithelial dysplasia--a novel mouse model providing insights into geleophysic dysplasia.

Authors:  Dirk Hubmacher; Lauren W Wang; Robert P Mecham; Dieter P Reinhardt; Suneel S Apte
Journal:  Dis Model Mech       Date:  2015-03-11       Impact factor: 5.758

8.  The Clinical Cases of Geleophysic Dysplasia: One Gene, Different Phenotypes.

Authors:  Evgenia Globa; Nataliya Zelinska; Andrew Dauber
Journal:  Case Rep Endocrinol       Date:  2018-07-03
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.